Underdiagnosis of cervical intraepithelial neoplasia (CIN) 2 or Worse Lesion in Women with a Previous Colposcopy-Guided Biopsy Showing CIN 1

• Published in: Revista Brasileira de ginecologia e obstetrícia 2017-03, Vol.39 (3), p.123-127
• Main Authors: Souza, Carlos André Scheler de, Discacciati, Michelle Garcia, d'Otavianno, Maria Gabriela, Bergo, Silvia Maria, Traue, Markus, Andrade, Liliana Aparecida Lucci de Angelo, Zeferino, Luiz Carlos
• Format: Article
• Language: English
• Subjects: Adult; Colposcopy; Female; Humans; Image-Guided Biopsy; Neoplasm Staging; Original; Uterine Cervical Dysplasia - pathology; Uterine Cervical Neoplasms - pathology; Young Adult
• ISSN: 0100-7203; 1806-9339
• DOI: 10.1055/s-0037-1599071

Expectant follow-up for biopsy-proven cervical intraepithelial neoplasia (CIN) 1 is the current recommendation for the management of this lesion. Nevertheless, the performance of the biopsy guided by colposcopy might not be optimal. Therefore, this study aimed to calculate the rate of underdiagnoses of more severe lesions in women with CIN 1 diagnosis and to evaluate whether age, lesion extent and biopsy site are factors associated with diagnostic failure.  Eighty women with a diagnosis of CIN 1 obtained by colposcopy-guided biopsy were selected for this study. These women were herein submitted to large loop excision of the transformation zone (LLETZ). The prevalence of lesions more severe than CIN 1 was calculated, and the histological diagnoses of the LLETZ specimens were grouped into two categories: "CIN 1 or less" and "CIN 2 or worse."  The prevalence of lesions diagnosed as CIN 2 or worse in the LLETZ specimens was of 19% (15/80). Three women revealed CIN 3, and 1 woman revealed a sclerosing adenocarcinoma stage I-a, a rare type of malignant neoplasia of low proliferation, which was not detected by either colposcopy or previous biopsy. The underdiagnosis of CIN 2 was not associated with the women's age, lesion extension and biopsy site.  The standard methods used for the diagnosis of CIN 1 may underestimate the severity of the true lesion and, therefore, women undergoing expectant management must have an adequate follow-up.